Join Meridian Bioscience at the Next Generation Dx Summit, hosted by the Cambridge Healthtech Institute which unites global leaders driving innovation in diagnostics. This year’s program covers a wide range of breakthrough areas—from liquid biopsy and infectious disease testing to companion diagnostics, clinical microbiology, and decentralized testing.
August 18, 2025 | 09:30 am EDT
Track: Enabling Point-of-Care Diagnostics – https://www.nextgenerationdx.com/point-of-care-diagnostics
Point-of-care diagnostics are reshaping how and where patients access healthcare. However, challenges around enzyme stabilization, cost, and logistics can limit their reach. In this session, William Ferreira explores how established and emerging molecular techniques—like qPCR, isothermal amplification, and NGS—can be adapted using ambient-stable reagents to enable rapid, scalable, and cost-effective testing at the point of care. Discover how Meridian’s technologies support the development of assays suitable for clinical labs, pharmacies, and at-home use.
William is an R&D Team Leader at Meridian Life Science. He earned his PhD in molecular microbiology in 2019, investigating C. difficile pathogenesis at Royal Holloway, University of London, UK. Subsequently, he held the position of Senior Scientist at Sporegen Ltd, leading diverse research projects rooted in recombinant spore technology. With more than 8 years of expertise in developing molecular assays for clinical use, William is a vital asset within Meridian’s R&D team. His role involves spearheading the creation of cutting-edge molecular products for the global diagnostic industry.
• Molecular point-of-care testing (qPCR, isothermal amplification, and next-generation sequencing)
• Ambient-stable reagent chemistries (lyophilization, cold-chain free)
• Infectious disease diagnostics
• Decentralized testing & rapid assay development
• Scalability in resource-limited or near-patient settings
While we are not exhibiting, Meridian will be available during the conference for discussions with our experts. Contact us to arrange a meeting or learn more about how our reagents and formulation expertise can accelerate your assay development pipeline.
